A Randomized, 6-period, 6-treatment, Single-Dose, Crossover Study to Assess the Pharmacokinetics of AZD5462 Film-coated Tablet Formulation, to Assess the Relative Bioavailability of AZD5462 Film-coated Tablet Formulation vs Oral Solution, and to Assess the Influence of Food on the Pharmacokinetics of AZD5462 in Healthy Participants
Latest Information Update: 16 Nov 2023
At a glance
- Drugs AZD 5462 (Primary) ; AZD 5462
- Indications Cardiovascular disorders
- Focus Pharmacokinetics
- Sponsors AstraZeneca
Most Recent Events
- 15 Nov 2022 Status changed from active, no longer recruiting to completed.
- 03 Nov 2022 Status changed from recruiting to active, no longer recruiting.
- 02 Sep 2022 Status changed from not yet recruiting to recruiting.